- Type: Injectable medications for Type 2 Diabetes
- Action: Mimics both GIP and GLP-1 hormones, enhancing insulin release, suppressing glucagon
- Benefits: Significant weight loss, improved glycemic control
- Risk: Gastrointestinal side effects, potential for low risk of pancreatitis
- Example: Tirzepatide
